Skip to main content
SpringerLink
Log in

Can Thiazide Diuretics be Recommended Routinely to Reduce Hip Fracture Risk?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Adland-Davenport P, McKenzie MW, Notelovitz M, McKenzie LC, Pendergast JF. Thiazide diuretics and bone mineral content in postmenopausal women. American Journal of Obstetrics and Gynecology 152: 630–634, 1985

    PubMed  CAS  Google Scholar 

  • Block JE, Smith R, Black D, Genant HK. Does exercise prevent osteoporosis? Journal of the American Medical Association 257: 3115–3117, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bostick RM, Luepker RV, Kofron PM, Pirie PL. Changes in physician practice for the prevention of cardiovascular disease. Archives of Internal Medicine 151: 478–484, 1991

    Article  PubMed  CAS  Google Scholar 

  • Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodelling. Journal of Clinical Investigation 81: 277–281, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cauley J, Seeley D, Cummings SR. Study of osteoporotic fractures research group, Kaiser Permanente Center for Health Research. Thiazide diuretics preserve bone mass and reduce the risk fractures in elderly women: a prospective study. Clinical Research 38: 452A, 1990

    Google Scholar 

  • Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. New England Journal of Medicine 327: 1637–1642, 1992

    Article  PubMed  CAS  Google Scholar 

  • Chow R, Harrison JE, Notarius C. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women. British Medical Journal 295: 1441–1444, 1987

    Article  PubMed  CAS  Google Scholar 

  • Christiansen C, Christensen MS, NcNair P, Hagen C, Stocklund KE, et al. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. European Journal of Clinical Investigations 10: 273–279, 1980

    Article  CAS  Google Scholar 

  • Cooper C, Barker DJP, Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. British Medical Journal 297: 1443–1446, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1: 581–584, 1987

    Article  PubMed  CAS  Google Scholar 

  • Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiology Review 7: 178–208, 1985

    CAS  Google Scholar 

  • Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. New England Journal of Medicine 323: 878–883, 1990

    Article  PubMed  CAS  Google Scholar 

  • Ellerington MC, Stevenson JC. Prevention of osteoporosis. Current recommendations. Drugs & Aging 2: 508–517, 1992

    Article  CAS  Google Scholar 

  • Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Annals of Internal Medicine 106: 40–45, 1987

    PubMed  CAS  Google Scholar 

  • Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. Journal of the American Medical Association 265: 370–373, 1991

    Article  PubMed  CAS  Google Scholar 

  • Freis ED. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol level. Archives of Internal Medicine 149: 2640–2649, 1989

    Article  PubMed  CAS  Google Scholar 

  • Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Annals of Internal Medicine 113: 649–655, 1990

    PubMed  CAS  Google Scholar 

  • Grazier KL, Holbrook TL, Kelsey JL, Stauffer RN. The frequency of occurrence, impact and cost of musculoskeletal conditions in the US. American Academy of Orthopedic Surgeons, Chicago, 1984

    Google Scholar 

  • Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Annals of Internal Medicine 115: 1–6, 1991

    PubMed  CAS  Google Scholar 

  • Heithoff KA, Lohr KN (Eds). Hip fracture: setting priorities for effectiveness research. Report of a study by a committee of the Institute of Medicine, Division of Health Care Services, National Academy Press, Washington, DC, 1990

    Google Scholar 

  • Holbrook TL, Barrett-Connor EC, Wingard D. Dietary calcium and risk of hip fracture: 14 year prospective population study. Lancet 2: 1046–1049, 1988

    Article  PubMed  CAS  Google Scholar 

  • Horsman A, Nordin BE, Simpson M, Speed R. Cortical and trabecular bone status in elderly women with femoral neck fracture. Clinical Orthopaedics and Related Research 166: 143–151, 1982

    PubMed  Google Scholar 

  • Hulley SB, Furberg CD, Gurland B, McDonald R, Perry HM, et al. Systolic Hypertension in the Elderly Program (SHEP): anti-hypertensive efficacy of chlorthalidone. American Journal of Cardiology 56: 913–920, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hunt I, Murphy N, Henderson C, Clark V, Coulson A. Bone mineral content in elderly women. Abstract, American Journal of Epidemiology 128: 903, 1988

    Google Scholar 

  • Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, et al. Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. American Journal of Public Health 80: 871–873, 1990

    Article  PubMed  CAS  Google Scholar 

  • Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. New England Journal of Medicine 317: 1169–1174, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kriska AM, Sandler RB, Cauley JA, LaPorte RE, Hom DL, et al. The assessment of historical physical activity and its relation to adult bone parameters. American Journal of Epidemiology 127: 1053–1063, 1988

    PubMed  CAS  Google Scholar 

  • LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, et al. Thiazide diuretic agents and the incidence of hip fracture. New England Journal of Medicine 322: 286–290, 1990

    Article  PubMed  CAS  Google Scholar 

  • Lindsay R, Marshall B, Haboubi A, Herrington BS, Tohme J. Increased axial bone mass in women with hypertension: role of thiazide therapy. Abstract. Journal of Bone and Mineral Research 2: S29, 1987

    Google Scholar 

  • Melton LJ, Wahner HW, Richelson LS, O’Fallon WM, Riggs BL. Osteoporosis and the risk of hip fracture. American Journal of Epidemiology 124: 254–261, 1986

    PubMed  Google Scholar 

  • Nevitt MC, Cummings SR, Kidd S, Black D. Risk factors for recurrent nonsyncopal falls. A prospective study. Journal of the American Medical Association 261: 2663–2668, 1989

    Article  PubMed  CAS  Google Scholar 

  • Ott SM, Chesnut III CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Annals of Internal Medicine 110: 267–274, 1989

    PubMed  CAS  Google Scholar 

  • Prince RL, Smith M, Dick IM, Price RI, Webb PG, et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. New England Journal of Medicine 325: 1189–1198, 1991

    Article  PubMed  CAS  Google Scholar 

  • Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association 262: 3303–3307, 1989a

    Article  PubMed  CAS  Google Scholar 

  • Ray WA, Griffin MR, Downey W, Melton LJ. Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1: 687–690, 1989b

    Article  PubMed  CAS  Google Scholar 

  • Ray WA. Thiazide diuretics and osteoporosis: time for a clinical trial? Annals of Internal Medicine 115: 64–65, 1991

    PubMed  CAS  Google Scholar 

  • Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2: 1481–1483, 1987

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, Melton III LJ. Involutional osteoporosis. New England Journal of Medicine 314: 1676–1686, 1986

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, Hodgson SF, O’Fallon WM, Chad EYS, Wahner HW, et al. Effect of fluoride treatment of the fracture rate in postmenopausal women with osteoporosis. New England Journal of Medicine 322: 802–809, 1990

    Article  PubMed  CAS  Google Scholar 

  • Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. New England Journal of Medicine 316: 173–177, 1987

    Article  PubMed  CAS  Google Scholar 

  • Seigel D, Hulley SB, Black DM, Cheitlin MD, Sebastian A, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. Journal of the American Medical Association 267: 1083–1089, 1992

    Article  Google Scholar 

  • SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Journal of the American Medical Association 265: 3255–3264, 1991

    Article  Google Scholar 

  • Sowers MF, Wallace RB, Lemke JH. Correlates of mid-radius bone density among postmenopausal women: a community study. American Journal of Clinical Nutrition 41: 1045–1053, 1985

    PubMed  CAS  Google Scholar 

  • Stevenson JC, Whitehead MI, Padwick M, Endacott JA, Sutton C, et al. Dietary intake of calcium and postmenopausal bone loss. British Medical Journal 297: 15–17, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sutton RA. Diuretics and calcium metabolism. American Journal of Kidney Diseases 1: 4–9, 1985

    Google Scholar 

  • Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. New England Journal of Medicine 326: 357–362, 1992

    Article  PubMed  CAS  Google Scholar 

  • Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. American Journal of Medicine 80: 429–434, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. New England Journal of Medicine 319: 1701–1707, 1988

    Article  PubMed  CAS  Google Scholar 

  • Transbol I, Christensen MS, Jensen GF, Christiansen C, McNair P. Thiazide for the postponement of postmenopausal bone loss. Metabolism 31: 383–386, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wasnich R, Davis J, Ross P, Vogel J. Effect of thiazide on rates of bone mineral loss: a longitudinal study. British Medical Journal 301: 1303–1305, 1990

    Article  PubMed  CAS  Google Scholar 

  • Wasnich RD, Benfante RJ, Yano K, Heilbrun L, Vogel JM. Thiazide effect on the mineral content of bone. New England Journal of Medicine 309: 344–347, 1983

    Article  PubMed  CAS  Google Scholar 

  • Wasnich RD, Ross PD, Heilbrun LK, Vogel JM, Yano K, et al. Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence. Obstetrics and Gynecology 67: 457–462, 1986

    PubMed  CAS  Google Scholar 

  • Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New England Journal of Medicine 323: 73–79, 1990

    Article  PubMed  CAS  Google Scholar 

  • Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. New England Journal of Medicine 303: 1195–1198, 1980

    Article  PubMed  CAS  Google Scholar 

  • Wickham CAC, Walsh K, Cooper C, Barder DJP, Margens BM, et al. Dietary calcium, physical activity, and risk of hip fracture: A prospective study. British Medical Journal 299: 889–892, 1989

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Medicine MCN A-1124, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232, USA

    Purushottam B. Thapa & Wayne A. Ray

Authors
  1. Purushottam B. Thapa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne A. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thapa, P.B., Ray, W.A. Can Thiazide Diuretics be Recommended Routinely to Reduce Hip Fracture Risk?. Drugs & Aging 3, 99–105 (1993). https://doi.org/10.2165/00002512-199303020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199303020-00001

Keywords

Search

Navigation